GAT211
|
G646624-10mg
|
≥99% |
102704-40-5 |
10mg
|
¥ 1300.9
|
期货,请咨询 |
阿拉丁 |
GAT211
|
G646624-100mg
|
≥99% |
102704-40-5 |
100mg
|
¥ 7200.9
|
期货,请咨询 |
阿拉丁 |
GSK-3484862
|
G646621-5mg
|
≥99% |
2170136-65-7 |
5mg
|
¥ 1500.9
|
期货,请咨询 |
阿拉丁 |
GSK-3484862
|
G646621-50mg
|
≥99% |
2170136-65-7 |
50mg
|
¥ 6500.9
|
期货,请咨询 |
阿拉丁 |
GSK-3484862
|
G646621-1mg
|
≥99% |
2170136-65-7 |
1mg
|
¥ 550.9
|
期货,请咨询 |
阿拉丁 |
GSK-3484862
|
G646621-10mg
|
≥99% |
2170136-65-7 |
10mg
|
¥ 2500.9
|
期货,请咨询 |
阿拉丁 |
GLPG0492
|
G646594-5mg
|
≥99% |
1215085-92-9 |
5mg
|
¥ 3500.9
|
期货,请咨询 |
阿拉丁 |
GLPG0492
|
G646594-50mg
|
≥99% |
1215085-92-9 |
50mg
|
¥ 15000.9
|
期货,请咨询 |
阿拉丁 |
GLPG0492
|
G646594-2mg
|
≥99% |
1215085-92-9 |
2mg
|
¥ 2333.9
|
期货,请咨询 |
阿拉丁 |
GLPG0492
|
G646594-10mg
|
≥99% |
1215085-92-9 |
10mg
|
¥ 5000.9
|
期货,请咨询 |
阿拉丁 |
GLPG0492
|
G646594-100mg
|
≥99% |
1215085-92-9 |
100mg
|
¥ 21000.9
|
期货,请咨询 |
阿拉丁 |
Gilteritinib hemifumarate
|
G646579-5mg
|
≥99% |
1254053-84-3 |
5mg
|
¥ 1000.9
|
期货,请咨询 |
阿拉丁 |
Gilteritinib hemifumarate
|
G646579-50mg
|
≥99% |
1254053-84-3 |
50mg
|
¥ 5600.9
|
期货,请咨询 |
阿拉丁 |
Gilteritinib hemifumarate
|
G646579-10mg
|
≥99% |
1254053-84-3 |
10mg
|
¥ 1600.9
|
期货,请咨询 |
阿拉丁 |
Gilteritinib hemifumarate
|
G646579-100mg
|
≥99% |
1254053-84-3 |
100mg
|
¥ 7100.9
|
期货,请咨询 |
阿拉丁 |
Gefitinib-d8
|
G646578-5mg
|
≥98% |
857091-32-8 |
5mg
|
¥ 18200.9
|
期货,请咨询 |
阿拉丁 |
Gefitinib-d8
|
G646578-1mg
|
≥98% |
857091-32-8 |
1mg
|
¥ 6500.9
|
期货,请咨询 |
阿拉丁 |
G5-7
|
G646574-5mg
|
≥99% |
939681-36-4 |
5mg
|
¥ 1600.9
|
期货,请咨询 |
阿拉丁 |
G5-7
|
G646574-25mg
|
≥99% |
939681-36-4 |
25mg
|
¥ 4300.9
|
期货,请咨询 |
阿拉丁 |
G5-7
|
G646574-1mg
|
≥99% |
939681-36-4 |
1mg
|
¥ 570.9
|
期货,请咨询 |
阿拉丁 |
G5-7
|
G646574-10mg
|
≥99% |
939681-36-4 |
10mg
|
¥ 2500.9
|
期货,请咨询 |
阿拉丁 |
GPR120 Agonist 2
|
G646571-5mg
|
≥99% |
1234844-11-1 |
5mg
|
¥ 2800.9
|
期货,请咨询 |
阿拉丁 |
GPR120 Agonist 2
|
G646571-50mg
|
≥99% |
1234844-11-1 |
50mg
|
¥ 12000.9
|
期货,请咨询 |
阿拉丁 |
GPR120 Agonist 2
|
G646571-1mg
|
≥99% |
1234844-11-1 |
1mg
|
¥ 1333.9
|
期货,请咨询 |
阿拉丁 |